Literature DB >> 11891419

Phenotypic variability in familial hypercholesterolaemia: an update.

Angelique C M Jansen1, Sanne van Wissen, Joep C Defesche, John J P Kastelein.   

Abstract

Heterozygous familial hypercholesterolaemia is among the most common inherited dominant disorders, and is characterized by severely elevated LDL-cholesterol levels and premature cardiovascular disease. Although the cause of familial hypercholesterolaemia is monogenic, there is a substantial variation in the onset and severity of atherosclerotic disease symptoms. Additional atherogenic risk factors of environmental, metabolic and genetic origin, in conjunction with the LDL receptor defect, are presumed to influence the clinical phenotype in familial hypercholesterolaemia. The present review discusses recent developments in this field.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891419     DOI: 10.1097/00041433-200204000-00008

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  16 in total

Review 1.  Genetic variation and lipid metabolism: modulation by dietary factors.

Authors:  Jose M Ordovas; Dolores Corella
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

2.  Perceived vulnerability to heart disease in patients with familial hypercholesterolemia: a qualitative interview study.

Authors:  Jan C Frich; Leiv Ose; Kirsti Malterud; Per Fugelli
Journal:  Ann Fam Med       Date:  2006 May-Jun       Impact factor: 5.166

Review 3.  Genetics of Dyslipidemia and Ischemic Heart Disease.

Authors:  Kavita Sharma; Ragavendra R Baliga
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

4.  Structure-Function Relationships of LDL Receptor Missense Mutations Using Homology Modeling.

Authors:  Sureerut Porntadavity; Nutjaree Jeenduang
Journal:  Protein J       Date:  2019-08       Impact factor: 2.371

5.  Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia.

Authors:  Alexina Orsoni; Elise F Villard; Eric Bruckert; Paul Robillard; Alain Carrie; Dominique Bonnefont-Rousselot; M John Chapman; Geesje M Dallinga-Thie; Wilfried Le Goff; Maryse Guerin
Journal:  J Lipid Res       Date:  2012-02-15       Impact factor: 5.922

6.  Management of Hyperlipidemia in the Pediatric Population.

Authors:  Serena Tonstad; Gilbert R. Thompson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10

7.  Low-density lipoprotein apheresis: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-11-01

Review 8.  Genetics of premature myocardial infarction.

Authors:  Robert Roberts
Journal:  Curr Atheroscler Rep       Date:  2008-06       Impact factor: 5.113

Review 9.  Dominant versus recessive: molecular mechanisms in metabolic disease.

Authors:  Johannes Zschocke
Journal:  J Inherit Metab Dis       Date:  2008-10-21       Impact factor: 4.982

10.  In search of a genetic explanation for LDLc variability in an FH family: common SNPs and a rare mutation in MTTP explain only part of LDL variability in an FH family.

Authors:  Michael Winther; Shoshi Shpitzen; Or Yaacov; Jakob Landau; Limor Oren; Linda Foroozan-Rosenberg; Naama Lev Cohain; Daniel Schurr; Vardiela Meiner; Auryan Szalat; Shai Carmi; Michael R Hayden; Eran Leitersdorf; Ronen Durst
Journal:  J Lipid Res       Date:  2019-08-06       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.